| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |